Citation Impact
Citing Papers
Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma
2003 StandoutNobel
Recognition of a Ubiquitous Self Antigen by Prostate Cancer-Infiltrating CD8 + T Lymphocytes
2008 StandoutScienceNobel
Programmed cell death 1 ligand 1 and tumor-infiltrating CD8 + T lymphocytes are prognostic factors of human ovarian cancer
2007 StandoutNobel
Telomere Dysfunction and DNA-PKcs Deficiency: Characterization and Consequence
2009
Disruption of the β1L Isoform of GABP Reverses Glioblastoma Replicative Immortality in a TERT Promoter Mutation-Dependent Manner
2018 StandoutNobel
The DNA-damage response in human biology and disease
2009 StandoutNature
T cell defined tumor antigens
1997
Tipin-Replication Protein A Interaction Mediates Chk1 Phosphorylation by ATR in Response to Genotoxic Stress
2010 StandoutNobel
Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma
1998 Standout
Distinct Neural Stem Cells Proliferate in Response to EGF and FGF in the Developing Mouse Telencephalon
1999
Stromal fibroblasts in cancer initiation and progression
2004 StandoutNature
Frequency analysis of tumor-reactive cytotoxic T lymphocytes in peripheral blood of a melanoma patient vaccinated with autologous tumor cells
1994
Phase 1 study of HPV16-specific immunotherapy with E6E7 fusion protein and ISCOMATRIX? adjuvant in women with cervical intraepithelial neoplasia
2004
Immune evasion in human papillomavirus-associated cervical cancer
2002
Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion
2005 Standout
Effect of TA-CIN (HPV 16 L2E6E7) booster immunisation in vulval intraepithelial neoplasia patients previously vaccinated with TA-HPV (vaccinia virus encoding HPV 16/18 E6E7)
2004
Loss of Net as Repressor Leads to Constitutive Increased c-fos Transcription in Cervical Cancer Cells
2004 StandoutNobel
Viruses in human cancers
1999 StandoutNobel
Integrins Form an Expanding Diffusional Barrier that Coordinates Phagocytosis
2016 StandoutNobel
The Human T Cell Response to Melanoma Antigens
2006
Generation and immunogenicity of novel HIV/AIDS vaccine candidates targeting HIV-1 Env/Gag-Pol-Nef antigens of clade C
2006
Adult Cardiac Stem Cells Are Multipotent and Support Myocardial Regeneration
2003 Standout
Chimeric Virus-like Particles of the Human Papillomavirus Type 16 (HPV 16) as a Prophylactic and Therapeutic Vaccine
1999
The use of dendritic cells in cancer immunotherapy
2003 StandoutNobel
Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia
2009
Epitope clustering in regions undergoing efficient proteasomal processing defines immunodominant CTL regions of a tumor antigen
2006
Enhancement of antitumour immunity by a novel chemotactic antigen DNA vaccine encoding chemokines and multiepitopes of prostate‐tumour‐associated antigens
2006
Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells
1999 StandoutNobel
Frequency of cytotoxic T lymphocyte precursors (CTLp) interacting with autologous tumor via the T‐cell receptor: Limiting dilution analysis of specific CTLp in peripheral blood and tumor‐invaded lymph nodes of melanoma patients
1994
The use of computer-assisted video image analysis for the quantification of CD8+ T lymphocytes producing tumor necrosis factor α spots in response to peptide antigens
1997
No attenuation of the ATM-dependent DNA damage response in murine telomerase-deficient cells
2008
Viruses in human cancers
1999 StandoutNobel
Dendritic cells: a journey from laboratory to clinic
2003
Papillomaviruses and cancer: from basic studies to clinical application
2002 StandoutNobel
Exploiting dendritic cells to improve vaccine efficacy
2002 StandoutNobel
Strategies for designing and optimizing new generation vaccines
2001
Taking dendritic cells into medicine
2007 StandoutNatureNobel
The evolution of checkpoint blockade as a cancer therapy: what's here, what's next?
2015
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell–mediated immunotherapy
2004
The causes and consequences of genetic heterogeneity in cancer evolution
2013 StandoutNature
Cancer immunotherapy comes of age
2011 StandoutNature
Stem Cell-derived Neural Stem/Progenitor Cell Supporting Factor Is an Autocrine/Paracrine Survival Factor for Adult Neural Stem/Progenitor Cells
2003 StandoutNobel
Phase I/II trial of immunogenicity of a human papillomavirus (HPV) type 16 E7 protein?based vaccine in women with oncogenic HPV-positive cervical intraepithelial neoplasia
2004
Mature dendritic cells boost functionally superior CD8+ T-cell in humans without foreign helper epitopes
2000 StandoutNobel
Novel methods to monitor antigen-specific cytotoxic T-cell responses in cancer immunotherapy
1998
Comparing effects of mTR and mTERT deletion on gene expression and DNA damage response: a critical examination of telomere length maintenance-independent roles of telomerase
2009 StandoutNobel
DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation
2003 StandoutNature
DNA-PKcs has KU-dependent function in rRNA processing and haematopoiesis
2020 StandoutNatureNobel
Vaccine and antibody-directed T cell tumour immunotherapy
2004
Cancer vaccines
1998
Therapeutic Vaccination for HPV Induced Cervical Cancers
2007
The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells
2008 StandoutNobel
The Hallmarks of Aging
2013 Standout
Rapid degradation of a large fraction of newly synthesized proteins by proteasomes
2000 StandoutNature
Immunogenicity of protein therapeutics
2007
The Tumor Suppressor Protein p16 and the Human Papillomavirus Oncoprotein-58 E7 Are Naturally Occurring Lysine-less Proteins That Are Degraded by the Ubiquitin System
2004 StandoutNobel
Precursor frequency analysis of human cytolytic T lymphocytes directed against autologous melanoma cells
1992
DNA damage response at functional and dysfunctional telomeres
2008
Fully mobilizing host defense: Building better vaccines
1998
Cancer immunotherapy with mRNA‐transfected dendritic cells
2004
NKT Cells Enhance CD4+ and CD8+ T Cell Responses to Soluble Antigen In Vivo through Direct Interaction with Dendritic Cells
2003
Exploiting dendritic cells to improve vaccine efficacy
2002 StandoutNobel
The Immunological Synapse: A Molecular Machine Controlling T Cell Activation
1999 StandoutScience
Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates
2011 StandoutNobel
Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes
2002 StandoutScience
Exploiting dendritic cells to improve vaccine efficacy
2002 StandoutNobel
New Approaches to Immunotherapy for HPV Associated Cancers
2011
Induction of cellular immunity by immunization with novel hybrid peptides complexed to heat shock protein 70
2000 StandoutNobel
Vaccination with Mage-3a1 Peptide–Pulsed Mature, Monocyte-Derived Dendritic Cells Expands Specific Cytotoxic T Cells and Induces Regression of Some Metastases in Advanced Stage IV Melanoma
1999 StandoutNobel
Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell–mediated immunotherapy
2004
Whole chromosome loss is promoted by telomere dysfunction in primary cells
2010
Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients
2003 StandoutNobel
A phase I trial of a human papillomavirus (HPV) peptide vaccine for women with high-grade cervical and vulvar intraepithelial neoplasia who are HPV 16 positive.
2000
Glycolipid α-C-galactosylceramide is a distinct inducer of dendritic cell function during innate and adaptive immune responses of mice
2006 StandoutNobel
Transport of Peptide-MHC Class II Complexes in Developing Dendritic Cells
2000 StandoutScienceNobel
Unique potential of 4-1BB agonist antibody to promote durable regression of HPV + tumors when combined with an E6/E7 peptide vaccine
2015 StandoutNobel
CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit
2008 StandoutNobel
Immunotherapy: Bewitched, Bothered, and Bewildered No More
2004 StandoutScienceNobel
How Shelterin Protects Mammalian Telomeres
2008 Standout
Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis.
2000
Enhanced Phosphorylation of p53 by ATM in Response to DNA Damage
1998 StandoutScience
Structure of Peptides Associated with Class I and Class II MHC Molecules
1994
Low-Dose Adenovirus Vaccine Encoding Chimeric Hepatitis B Virus Surface Antigen-Human Papillomavirus Type 16 E7 Proteins Induces Enhanced E7-Specific Antibody and Cytotoxic T-Cell Responses
2005 StandoutNobel
Molecular Mechanisms of Mammalian DNA Repair and the DNA Damage Checkpoints
2004 StandoutNobel
Liquid phase condensation in cell physiology and disease
2017 StandoutScience
ATAXIA-TELANGIECTASIA AND THE NIJMEGEN BREAKAGE SYNDROME: Related Disorders But Genes Apart
1997
Recombinant immunotoxin for cancer treatment with low immunogenicity by identification and silencing of human T-cell epitopes
2014 StandoutNobel
Works of Stephen Man being referenced
High levels of allele loss at the FHIT and ATM genes in non-comedo ductal carcinoma in situ and grade I tubular invasive breast cancers.
1996
Clinical studies of human papilloma vaccines in pre-invasive and invasive cancer
2001
The nature of telomere fusion and a definition of the critical telomere length in human cells
2007
CD200 expression suppresses natural killer cell function and directly inhibits patient anti-tumor response in acute myeloid leukemia
2011
Role of endogenous peptide in human alloreactive cytotoxic T cell responses
1992
Limiting dilution analysis of human T cells: a useful clinical tool
1990
Induction of viral and tumour specific CTL responses using antibody targeted HLA class I peptide complexes
2002
A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer
1996
Definition of a human T cell epitope from influenza A non-structural protein 1 using HLA-A2.1 transgenic mice
1995
Human T-cell responses to HLA-A-restricted high binding affinity peptides of human papillomavirus type 18 proteins E6 and E7.
2001
Antigen Processing Defects in Cervical Carcinomas Limit the Presentation of a CTL Epitope from Human Papillomavirus 16 E6
2001
Human papillomavirus type 16 E6/E7‐specific cytotoxic T lymphocytes in women with cervical neoplasia
2000
Defined Flanking Spacers and Enhanced Proteolysis Is Essential for Eradication of Established Tumors by an Epitope String DNA Vaccine
2001
Competition Between CTL Narrows the Immune Response Induced by Prime-Boost Vaccination Protocols
2002
A naturally processed peptide presented by HLA-A*0201 is expressed at low abundance and recognized by an alloreactive CD8+ cytotoxic T cell with apparent high affinity.
1997
Human papillomavirus type 16 E6/E7-specific cytotoxic T lymphocytes in women with cervical neoplasia
2000
ANALYSIS OF THE ALLOREACTIVE T CELL REPERTOIRE IN MAN
1987
Infiltration of cervical cancer tissue with human papilloma virus-specific cytotoxic T-lymphocytes
1997
Human papillomavirus-specific cytotoxic T lymphocytes in patients with cervical intraepithelial neoplasia grade III.
1997
Immunological Responses in Women with Human Papillomavirus Type 16 (HPV-16)-Associated Anogenital Intraepithelial Neoplasia Induced by Heterologous Prime-Boost HPV-16 Oncogene Vaccination
2004
Use of fluorogenic histocompatibility leukocyte antigen-A*0201/HPV 16 E7 peptide complexes to isolate rare human cytotoxic T-lymphocyte-recognizing endogenous human papillomavirus antigens.
2000